This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
The Rosen Law Firm, P.A. announces that it is investigating potential civil securities claims against Nu Skin Enterprises Inc. (NYSE: NUS) resulting from allegations that the Nu Skin is operating an illegal pyramid scheme in the People’s Republic of China (“PRC”).
On January 15, 2014, shares of Nu Skin fell dramatically following an article published in the People’s Daily newspaper alleging that the Company’s Chinese operations constitute a pyramid scheme in violation of PRC laws. On this news, shares of Nu Skin fell $21.24 per share, or by approximately 16%, from its previous closing price to close at $115.23 on January 15, 2014.
On January 16, 2014, the State Administration for Industry and Commerce of the People’s Republic of China announced an investigation of the Nu Skin stemming from the People’s Daily report. Nu Skin then issued an announcement stating that it was conducting its own province-by-province review and noted that this would likely have a negative impact on China revenue. On this news, shares of Nu Skin fell as much as 40% during intraday trading.
The Rosen Law Firm is preparing a class action lawsuit as a result of this adverse information. If you purchased Nu Skin securities, you may visit the website at
http://rosenlegal.com to join the action. You may also contact Phillip Kim, Esq. or Jonathan Horne, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:Laurence Rosen, Esq.Phillip Kim, Esq.Jonathan Horne, Esq.The Rosen Law Firm P.A.275 Madison Avenue 34
th FloorNew York, New York 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827